Contents
Academy · Research Data, Analytics & AI · Medical Device Safety and Risk Management Under ISO 14971: Process, Residual Risk and Lifecycle Requirements
Medical Device Safety and Risk Management Under ISO 14971: Process, Residual Risk and Lifecycle Requirements
ISO 14971 does not require a manufacturer to eliminate every risk associated with a device. It requires a documented, defensible account of the risks that remain and of why that residual risk is acceptable. This article outlines the process the standard defines and its lifecycle requirements.
Medical device risk management is the systematic process, defined internationally by ISO 14971, of identifying hazards associated with a medical device, estimating and evaluating the associated risks, controlling those risks and monitoring the effectiveness of those controls throughout the device’s lifecycle.
Learning objectives
- What ISO 14971 requires, as a process rather than a single document.
- The risk management lifecycle: identification, estimation, evaluation, control and post-market monitoring.
- Why acceptable residual risk, rather than zero risk, is the objective of the standard.
- How risk management connects to a device's clinical evaluation.
Common misconceptions
- “Risk management means eliminating all risk from a device.” ISO 14971 states explicitly that risk management aims to reduce risk to an acceptable level in view of the device’s benefits, documenting residual risk rather than requiring its complete elimination, which is rarely achievable for any medical device.
- “Risk management produces a single document at the time of submission.” ISO 14971 frames risk management as a lifecycle process that continues through design, manufacture and post-market use, with the risk management file updated as new information, including post-market surveillance data, becomes available.
The risk management process defined by ISO 14971
ISO 14971, the international standard for application of risk management to medical devices, sets out a defined process: identify hazards and hazardous situations associated with the device, estimate the risk associated with each (combining the probability of harm occurring and the severity of that harm), evaluate whether that risk is acceptable against defined criteria, and where it is not, implement risk control measures and re-evaluate the resulting residual risk. The standard requires this process to be documented in a risk management file that a manufacturer can produce on request.
Residual risk as the objective of the standard
A common misreading of ISO 14971 treats it as demanding risk elimination. The standard's objective is residual risk that is acceptable when weighed against the device's benefits — after reasonable risk control measures have been applied, some risk typically remains, and the standard requires that remaining risk to be explicitly evaluated and documented, with an overall benefit-risk determination made for the device as a whole, not only risk by risk.
Risk management as a lifecycle process
ISO 14971 frames risk management as continuing beyond initial approval: production and post-production information, including complaints, adverse event reports, and post-market surveillance data, feeds back into the risk management file, and the manufacturer is expected to review and update its risk analysis in light of that information. This lifecycle requirement is what connects a device's risk management file to its clinical evaluation report and to post-market surveillance activity, rather than treating each as a separate, disconnected submission requirement.
Key points
Key points
ISO 14971 defines medical device risk management as a documented lifecycle process of identifying hazards, estimating and evaluating the associated risks, controlling them and monitoring residual risk against the device’s benefits; its objective is an acceptable, documented residual risk rather than the elimination of risk.
Practical application
Practical application
- The risk management file should be maintained as a living document. It should be structured for updating with post-market surveillance and complaint data rather than filed once at submission.
- Residual risk and the benefit–risk determination should be documented explicitly. The file should state the risk remaining after control measures and the explicit judgement that this residual risk is acceptable in view of the device’s benefits.
- Risk management should be linked to clinical evaluation and post-market surveillance. Findings from post-market monitoring should inform the hazard analysis in the risk management file rather than being tracked as a separate, unconnected process.
Frequently asked questions
Yes; the risk management process applies to medical devices generally, including software, though specific hazards and controls differ by device type.
A hazard is a potential source of harm; risk combines the probability that a hazardous situation leads to harm with the severity of that harm, which is the quantity the standard requires manufacturers to estimate and evaluate.
No; they are linked but distinct documents — the risk management file documents the hazard-and-risk process, while the clinical evaluation report assesses clinical data supporting the device's safety and performance.
References
- International Organization for Standardization. ISO 14971:2019, Medical devices — Application of risk management to medical devices. read 10 October 2026. View ISO 14971:2019
Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.
Pubrica Academy. (2026, October 10). Medical Device Safety and Risk Management Under ISO 14971: Process, Residual Risk and Lifecycle Requirements. Pubrica. https://pubrica.com/academy/concepts-definitions/medical-device-safety-and-risk-management/
Pubrica Academy. “Medical Device Safety and Risk Management Under ISO 14971: Process, Residual Risk and Lifecycle Requirements.” Pubrica, 10 Oct. 2026, pubrica.com/academy/concepts-definitions/medical-device-safety-and-risk-management/.
Pubrica Academy (2026) Medical Device Safety and Risk Management Under ISO 14971: Process, Residual Risk and Lifecycle Requirements. Pubrica. Available at: https://pubrica.com/academy/concepts-definitions/medical-device-safety-and-risk-management/ (Accessed: 15 October 2026).
Pubrica Academy. “Medical Device Safety and Risk Management Under ISO 14971: Process, Residual Risk and Lifecycle Requirements.” Pubrica. October 10, 2026. https://pubrica.com/academy/concepts-definitions/medical-device-safety-and-risk-management/
Pubrica Academy, ‘Medical Device Safety and Risk Management Under ISO 14971: Process, Residual Risk and Lifecycle Requirements’ (Pubrica, 10 October 2026) <https://pubrica.com/academy/concepts-definitions/medical-device-safety-and-risk-management/> accessed 15 October 2026.
Pubrica Academy. Medical Device Safety and Risk Management Under ISO 14971: Process, Residual Risk and Lifecycle Requirements. [Internet]. Pubrica; 2026 Oct 10 [cited 2026 Oct 15]. Available from: https://pubrica.com/academy/concepts-definitions/medical-device-safety-and-risk-management/
Pubrica Academy, “Medical Device Safety and Risk Management Under ISO 14971: Process, Residual Risk and Lifecycle Requirements,” Pubrica, Oct. 10, 2026. [Online]. Available: https://pubrica.com/academy/concepts-definitions/medical-device-safety-and-risk-management/
@misc{medical_device_safety_risk_management_2026,
author = {{Pubrica Academy}},
title = {Medical Device Safety and Risk Management Under ISO 14971: Process, Residual Risk and Lifecycle Requirements},
howpublished = {Pubrica},
year = {2026},
month = {oct},
url = {https://pubrica.com/academy/concepts-definitions/medical-device-safety-and-risk-management/},
note = {Accessed: <span data-cite-acc="iso">2026-10-15</span>}
}This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
Risk management file structure stub
For use when building or reviewing a device's risk management file.
Hazard identified: ____ Hazardous situation: ____ Probability of harm: ____ Severity of harm: ____ Initial risk evaluation: acceptable / not acceptable Risk control measure(s) applied: ____ Residual risk evaluation: ____ Overall benefit-risk determination: ____
Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.
How Pubrica can help
Pubrica’s regulatory-writing team develops and maintains risk management files according to the ISO 14971 structure, linking hazard analysis to clinical evaluation and post-market surveillance data as required by the standard’s lifecycle approach.